Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can’t be surgically removed.
The platform allows for greater precision and thoroughness in cancer treatment.
Here’s how it works:
Nanoparticles tightly loaded with a dye compound are administered systemically – injected intravenously or into the peritoneum, the abdominal cavity. When they reach the tumor site, the tumor’s intracellular environment effectively flips the switch on the compound’s fluorescence.
That enables detection by a near infrared (NIR) imaging system that helps surgeons know in real time what needs to be removed.
Any glowing areas that can’t be cut out are given phototherapy – irradiated with a near infrared laser, which causes the nanoparticles to heat up and kill the residual cancer cells.
The findings by researchers in the OSU/OHSU College of Pharmacy and OSU College of Veterinary Medicine were published this month in Theranostics.
The nanomedicine platform consists of silicon naphthalocyanine (SiNc) densely packed in biodegradable PEG-PCL nanoparticles. Because the SiNc is engineered to be non-fluorescent initially – until the tumor activates the fluorescence by loosening the packing – it doesn’t cause any non-cancerous tissue to glow.
Corresponding authors Olena Taratula and Oleh Taratula of the Department of Pharmaceutical Sciences and their collaborators evaluated the platform in vitro and in two different mouse models, including one that mimicked ovarian intraperitoneal metastasis.
The research team operated on the mice using real-time imaging, which showed that the new nanoparticles are compatible with a standard, FDA-approved imaging system. The efficacy of the phototherapy was also demonstrated in vivo.
“The nanoplatform system is quite simple but quite effective,” Olena Taratula said.
Subsequent laboratory testing of the platform will include rats, she said, followed by testing on dogs that are already scheduled for cancer surgeries at the College of Veterinary Medicine.
“They’re going to do surgery on those dogs anyway, and they can use our nanomedicine platform as an additional tool to see if they can identify the cancer cells,” Taratula said.
The Latest on: Flourescent nanomedicine
- Eno E. Ebong, Ph.D.on March 20, 2020 at 5:37 pm
In vascular regions where blood flow is laminar, the endothelial cells that line the inner vessel wall are healthy and the vessel is protected from disease. Disturbed flow, which is low and ...
- Quantification of Nanoparticles at the Single-cell Level: An Overview About State-of-the-art Techniques and Their Limitationson March 18, 2020 at 5:00 pm
Nanomedicine. 2014;9(12):1885-1900 ... blue will have no significant effect on diminishing the extracellular fluorescent signal. Thus, in such cases additional washing steps have been suggested ...
- Protecting DNA origami for anti-cancer drug deliveryon March 9, 2020 at 12:03 pm
"One of the limiting factors in applying the structure and shape benefits of DNA origami to nanomedicine is that, placed inside the human body ... DNA and peptoids. Experiments with fluorescent dye ...
- Protecting DNA origami for anti-cancer drug deliveryon March 8, 2020 at 5:00 pm
"One of the limiting factors in applying the structure and shape benefits of DNA origami to nanomedicine is that ... Experiments with fluorescent dye (which binds to the DNA) showed that a ...
- Molecular Imaging News and Researchon March 4, 2020 at 4:00 pm
On Target Laboratories Inc., a privately held biotechnology company developing the use of Purdue University-discovered fluorescent ... congress of the French Nanomedicine Society (SFNano), and ...
- Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapyon February 28, 2020 at 2:04 am
In total, our work offers a method to in situ hitchhike circulating neutrophils with pathogen-mimicking NPNs for improved nanomedicine ... in vivo fluorescent images were observed with IVIS.
- Liposomal Nanomedicine for Breast Cancer Therapyon February 19, 2020 at 4:00 pm
CMV-SPORT-β-gal Haloperidol Sigma receptors Haloperidol-conjugated targeted lipoplex showed tenfold higher reporter gene expression in MCF-7 cells in comparison to control lipoplex  p53 ...
- UMass NanoMedicine Instituteon April 2, 2019 at 10:13 am
000 seed grant from the UMass President's Office to establish the UMass NanoMedicine Institute. Scientists at the Institute will collaborate to develop novel fluorescent, magnetic diagnostics, and ...
- Nanobiotechnology and Nanomedicine Companieson September 12, 2018 at 1:10 am
These Molecular Dots can encapsulate drugs and/or fluorescent molecules. The combination of a protected blood transporting nanocarrier system and a tumor specific activation technology makes LiPlasome ...
- MSK-Cornell Center for Translation of Cancer Nanomedicineon March 6, 2018 at 8:33 am
The goal of the MSK-Cornell Center for Translation of Cancer Nanomedicine (MC 2 TCN) is to advance, translate, and disseminate a suite of ultrasmall (
via Google News and Bing News